First human tests begin for new Immune-Targeting drug
NCT ID NCT07090655
Summary
This is a very early safety study testing a new drug called budoprutug in healthy volunteers. Researchers will give single injections to 38 healthy adults to see how safe the drug is and how the body processes it. The main goal is to understand side effects and determine appropriate doses for future studies in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Brisbane
Brisbane, Australia
Conditions
Explore the condition pages connected to this study.